Impact of computed tomography (CT) and 18F-deoxyglucose- coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers;Tomographie par émission de positons et détection en coïncidence (TEDC) et recalage d'images de simulation virtuelle par tomodensitométrie. Impact sur la planification de la radiothérapie conformationnelle des cancers bronchiques non à petites cellules

Cancer/Radiotherapie

Volumn 9, Issue 5, 2005, Pages 304-315

  Deniaud Alexandre, E ^a   Touboul, E ^a   Lerouge, D ^a   Grahek, D ^a   Foulquier, J N ^a   Petegnief, Y ^a   Gres B ^a   El Balaa, H ^a   Keraudy, K ^a   Kerrou, K ^a   Montravers, F ^a   Milleron, B ^a   Lebeau, B ^b   Talbot, J N ^a  

^a HÔPITAL TENON   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

18F deoxyglucose PET imaging; Computed tomography; Image fusion; Non small cell lung cancer; Three dimensional conformal radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER LOCALIZATION; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEART VOLUME; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TOTAL LUNG CAPACITY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ATELECTASIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 26844473436     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.07.002     Document Type: Article

References (35)

1. J. Bradley, W.L. Thorstad, S. Mutic, T.R. Miller, F. Dehdashti, and B.A. Siegel Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 59 2004 78 86
2. A.J. Caggiano, C. Vialotti, and J. Brunetti 4D PET/CT-early observations on integration and impact in radiation therapy planning for lung cancer (Abstact) Int. J. Radiat. Oncol. Biol. Phys. 60 2004 s290
3. C.B. Caldwell, K. Mah, Y.C. Ung, C.E. Danjoux, J.M. Balogh, and S. Nimu Ganguli Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion Int. J. Radiat. Oncol. Biol. Phys. 51 2001 923 931
4. J.D. Chapman, J.D. Bradley, J.F. Eary, R. Haubner, S.M. Larson, and J.M. Michalski Molecular (functional) imaging for radiotherapy applications: an RTOG symposium Int. J. Radiat. Oncol. Biol. Phys. 55 2003 294 301
5. I.F. Ciernik, E. Dizendorf, B.G. Baumert, B. Reiner, C. Burger, and J.B. Davis Radiation treatment planning with an integrated positron-emission and computer tomography (PET/CT): a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 57 2003 853 863
6. e congr̀s national de la SFRO (ŕsuḿ) Cancer/Radiother. 6 2002 141s
7. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goiten, and J.E. Mundenrider Tolerance of normal tissue to therapeutic irradiation Int. J. Radiat. Oncol. Biol. Phys. 21 1991 109 122
8. Y. Erdi, K. Rosenzweig, A.K. Erdi, H.A. Macapinlac, Y.C. Hu, and L.E. Braban Radiotherapy treatment planning for patients with non-small-cell lung cancer using positron-emission tomography (PET) Radiother. Oncol. 62 2002 51 60
9. J.L. Fox, R. Rengan, W. O'Meara, E. Yorke, Y. Erdi, and S. Nehmeh Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineation tumor volumes for non-small-cell lung cancer? Int. J. Radiat. Oncol. Biol. Phys. 62 2005 70 75
10. P. Giraud, M. Antoine, A. Larrouy, B. Milleron, P. Callard, and Y. De Rycke Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning Int. J. Radiat. Oncol. Biol. Phys. 48 2000 1015 1024
11. P. Giraud, D. Grahek, F. Montravers, M.F. Carette, E. Deniaud-Alexandre, and F. Julia CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1249 1257
12. P. Giraud, Y. De Rycke, B. Dubray, S. Helfre, D. Voican, and L. Guo Conformal radiotherapy planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing Int. J. Radiat. Oncol. Biol. Phys. 51 2001 1081 1092
13. P. Giraud, P. Elles, S. Helfre, Y. De Rycke, V. Servois, and M.F. Carette Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists Radiother. Oncol. 62 2002 27 36
14. G.W. Goerres, E. Karnel, T.N. Heidelberg, M.R. Schwitter, C. Burger, and G.K. Von Schulthess PET/CT image coregistration in the thorax: influence of respiration Eur. J. Nucl. Med. 29 2002 351 360
15. M.V. Graham, J.A. Purdy, B. Emami, W. Harms, W. Bosch, and M.A. Lockett Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC) Int. J. Radiat. Oncol. Biol. Phys. 45 1999 323 329
16. J.S. Greenberger, A. Kalend, F. Sciurba, J.R. Jett, R. Landreneau, and C. Belani Development of multifield three-dimensional conformal radiotherapy of lung cancer using a total dose-volume histogram Radiat. Oncol. Invest. 3 1996 243 255
17. S. Hirota, K. Tsujino, M. Endo, Y. Kotani, M. Satouchi, and T. Kado Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin-paclitaxel-radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 51 2001 291 295
18. International commission on radiation units and measurements ICRU report 50: prescribing, recording, and reporting photon beam therapy 1993 International commission on radiation units and measurements Bethesda, MD
19. International commission on radiation units and measurements ICRU report 62: prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50) 1999 International commission on radiation units and measurements Bethesda, MD
20. J.D. Kiffer, S.U. Berlangieri, A.M. Scott, G. Quong, M. Feigen, and W. Schumer The contribution of 18F-fluorodeoxyglucose positron-emission tomographic imaging to radiotherapy planning in lung cancer Lung Cancer 19 1998 167 177
21. D. Lardinois, W. Weder, T.F. Hany, E.M. Kamel, S. Korom, and B. Seifert Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N. Engl. J. Med. 348 2003 2500 2507
22. M.P. Mac Manus, R.J. Hicks, D.L. Ball, V. Kalff, J.P. Matthews, and E. Salminen F-18-fluorodeoxyglucose positron-emission tomography staging in radical radiotherapy candidates with non-small-cell lung carcinoma Cancer 92 2001 886 895
23. M.P. Mac Manus, K. Wong, R. Hicks, J.P. Matthews, A. Wirth, and D.L. Ball Early mortality after radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center Int. J. Radiat. Oncol. Biol. Phys. 52 2002 351 361
24. K. Mah, C.B. Caldwell, Y.C. Ung, C.E. Danjoux, J.M. Balogh, and S.N. Ganguli The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int. J. Radiat. Oncol. Biol. Phys. 52 2002 339 350
25. M.T. Munley, L.B. Marks, C. Scarfone, G.S. Sibley, E.F. Patz, and T.G. Turkington Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects Lung Cancer 23 1999 105 114
26. 18F-deoxyglucose positron-emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int. J. Radiat. Oncol. Biol. Phys. 44 1999 593 597
27. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 320
28. R.M. Pieterman, J.W. Van Putten, J.J. Meuzelaar, E.L. Mooyaart, W. Vaalburg, and G.H. Koeter Preoperative staging of non-small-cell lung cancer with positron-emission tomography N. Engl. J. Med. 343 2000 254 261
29. A.J. Poncelet, M. Lonneux, E. Coche, B. Weynand, and P. Noirhomme PET-FDG scan enhances but does not replace preoperative surgical staging in non-small-cell lung carcinoma Eur. J. Cardiothorac. Surg. 20 2001 468 474
30. S. Senan, D. De Ruysscher, P. Giraud, R. Mirimanoff, V. Budach on behalf of the radiotherapy group of the European organization for research and treatment of cancer (EORTC). Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer Radiother. Oncol. 71 2004 139 146
31. S. Senan, O. Chapet, F.J. Lagerwaard, and R.K. Ten Haken Defining target volumes for non-small-cell lung carcinoma Semin. Radiat. Oncol. 14 2004 308 314
32. Standards, options et recommandations. Utilisation de la tomographie par ́mission de positons au [18F]-FDG en canćrologie. Ŕsultats dans les cancers bronchopulmonaires et pleuraux Bull. Cancer 90 2003 s23 s41
33. J. Van de Steene, N. Linthout, J. de Mey, V. Vinh-Hung, C. Claasens, and M. Noppen Definition of gross tumor volume in lung cancer: interobserver variability Radiother. Oncol. 62 2002 37 49
34. J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn, P.J. Dupont, J. Bogaert, and A. Maes Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients J. Clin. Oncol. 16 1998 2142 2149
35. 18F-fluoro-2-deoxy-D-glucose positron-emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small-cell lung cancer Radiother. Oncol. 55 2000 317 324